Viking Therapeutics, Inc. (NASDAQ:VKTX) Q2 2025 Earnings Call Transcript

Viking Therapeutics, Inc. (NASDAQ:VKTX) Q2 2025 Earnings Call Transcript July 23, 2025

Viking Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.58 EPS, expectations were $-0.44.

Operator: Welcome to the Viking Therapeutics Second Quarter 2025 Financial Results Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded today, July 23, 2025. I would now like to turn the conference over to Viking’s Manager of Investor Relations,...